These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29978039)

  • 21. Previous dengue or Zika virus exposure can drive to infection enhancement or neutralisation of other flaviviruses.
    Oliveira RA; de Oliveira-Filho EF; Fernandes AI; Brito CA; Marques ET; Tenório MC; Gil LH
    Mem Inst Oswaldo Cruz; 2019; 114():e190098. PubMed ID: 31411310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential immunization with heterologous chimeric flaviviruses induces broad-spectrum cross-reactive CD8+ T cell responses.
    Singh R; Rothman AL; Potts J; Guirakhoo F; Ennis FA; Green S
    J Infect Dis; 2010 Jul; 202(2):223-33. PubMed ID: 20536361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
    Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition of the region on NS3 which contains multiple epitopes recognized by dengue virus serotype-cross-reactive and flavivirus-cross-reactive, HLA-DPw2-restricted CD4+ T cell clones.
    Okamoto Y; Kurane I; Leporati AM; Ennis FA
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():697-704. PubMed ID: 9568963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice.
    Li J; Gao N; Fan D; Chen H; Sheng Z; Fu S; Liang G; An J
    Sci Rep; 2016 Jan; 6():19953. PubMed ID: 26818736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of the cross-reactive epitopes of Japanese encephalitis virus envelope glycoprotein.
    Chiou SS; Fan YC; Crill WD; Chang RY; Chang GJ
    J Gen Virol; 2012 Jun; 93(Pt 6):1185-1192. PubMed ID: 22337639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Live chimeric and inactivated Japanese encephalitis virus vaccines differ in their cross-protective values against Murray Valley encephalitis virus.
    Lobigs M; Larena M; Alsharifi M; Lee E; Pavy M
    J Virol; 2009 Mar; 83(6):2436-45. PubMed ID: 19109382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
    Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
    J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
    Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
    BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses.
    Holbrook MR; Shope RE; Barrett AD
    J Clin Microbiol; 2004 Sep; 42(9):4101-10. PubMed ID: 15364996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Anti-Premembrane Antibody as a Serocomplex-Specific Marker To Discriminate Zika, Dengue, and West Nile Virus Infections.
    Hsieh SC; Tsai WY; Tsai JJ; Stone M; Simmons G; Busch MP; Lanteri M; Stramer SL; Balmaseda A; Harris E; Wang WK
    J Virol; 2021 Sep; 95(19):e0061921. PubMed ID: 34232731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus.
    Salem GM; Galula JU; Wu SR; Liu JH; Chen YH; Wang WH; Wang SF; Song CS; Chen FC; Abarientos AB; Chen GW; Wang CI; Chao DY
    Commun Biol; 2024 Jan; 7(1):15. PubMed ID: 38267569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetics and cross-reactivity of the virus-specific antibody-forming cells in mice during primary and secondary infection with Japanese encephalitis virus and related flaviviruses.
    Garciá García J; Takashima I; Kariwa H; Hashimoto N
    J Virol Methods; 1994 Jun; 48(1):31-41. PubMed ID: 7962258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4
    Wen J; Wang YT; Valentine KM; Dos Santos Alves RP; Xu Z; Regla-Nava JA; Ngono AE; Young MP; Ferreira LCS; Shresta S
    Cell Rep; 2020 Apr; 31(4):107566. PubMed ID: 32348763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine.
    Kayser M; Klein H; Paasch I; Pilaski J; Blenk H; Heeg K
    J Med Virol; 1985 Sep; 17(1):35-45. PubMed ID: 2995571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Japanese encephalitis virus prM-E antigen immunization conferred protection against challenge by four different serotypes of Dengue viruses in mice.
    Gao N; Li J; Sheng Z; Chen H; Fan D; Wang P; An J
    Appl Microbiol Biotechnol; 2019 Jun; 103(12):4977-4986. PubMed ID: 31037380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope mapping of flavivirus glycoproteins.
    Heinz FX
    Adv Virus Res; 1986; 31():103-68. PubMed ID: 2428213
    [No Abstract]   [Full Text] [Related]  

  • 40. Cross-Reactive Antibodies during Zika Virus Infection: Protection, Pathogenesis, and Placental Seeding.
    Zimmerman MG; Wrammert J; Suthar MS
    Cell Host Microbe; 2020 Jan; 27(1):14-24. PubMed ID: 31917957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.